Association of CRTH2 gene polymorphisms with the required dose of antihistamines in patients with chronic urticaria

Pharmacogenomics

Volumn 10, Issue 3, 2009, Pages 375-383

  Palikhe, Nami Shrestha ^a   Kim, Seung Hyun ^a   Ye, Young Min ^a   Hur, Gyu Young ^a   Cho, Bo Young ^a   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Antihistamine drugs; Chronic urticaria; CRTH2; Polymorphism

Indexed keywords

ADENINE; ANTIHISTAMINIC AGENT; AUTOANTIBODY; BETOTASTINE; CHLORPHENIRAMINE; CIMETIDINE; CYTOSINE; DEFLAZACORT; EBASTINE; EPINASTINE; FEXOFENADINE; HYDROXYZINE; IMMUNOGLOBULIN E; LORATADINE; LUCIFERASE; METHYLPREDNISOLONE; PENIRAMIN; PREDNISOLONE; STEROID; THYMINE; TRANSCRIPTION FACTOR GATA 3; UCERAX; UNCLASSIFIED DRUG; GATA3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; PRIMER DNA; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR;

ARTICLE; ATOPY; CHRONIC URTICARIA; CONTROLLED STUDY; CRTH 2 GENE; DISEASE DURATION; DNA POLYMORPHISM; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MAST CELL; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL; ZYGOSITY; BLOOD; CELL LINE; CHRONIC DISEASE; GENETIC TRANSFECTION; GENETICS; HISTAMINE RELEASE; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMID; PROMOTER REGION; REFERENCE VALUE; URTICARIA;

CELL LINE; CHRONIC DISEASE; DNA PRIMERS; GATA3 TRANSCRIPTION FACTOR; GENE FREQUENCY; GENOTYPE; HISTAMINE ANTAGONISTS; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; PHENOTYPE; PLASMIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; REFERENCE VALUES; TRANSFECTION; URTICARIA;

EID: 65649145676     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.10.3.375     Document Type: Article

References (35)

1. Hennino A, Berard F, Guillot I et al.: Patholophysiology of urticaria. Clin. Rev. Allergy Immunol. 30, 3-11 (2006).
2. Ring J, Brockow K, Ollert M et al.: Antihistamines in urticaria. Clin. Exp. Allergy 29, 31-37 (1999).
3. Lewis RA, Austen KF: Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds. Nature 293, 103-108 (1981).
4. Murray JJ, Tonnel AB, Brash AR et al.: Prostaglandin D2 is released during acute allergic bronchospasm in man. Trans. Assoc. Am. Physicians 98, 275-280 (1985).
5. Murray JJ, Tonnel AB, Brash AR et al.: Release of prostaglandin D2 into human airways during acute antigen challenge. N. Engl. J. Med. 315, 800-804 (1986).
6. Wenzel SE, Westcott JY, Larsen GL: Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatics responses. J. Allergy Clin. Immunol. 87, 540-548 (1991).
7. Nagata K, Hirai H, Tanaka K et al.: CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett. 459, 195-199 (1999).
8. Monneret G, Gravel S, Diamond M et al.: Prostaglandin D2 potent chemo attractant for human eosinophils that acts via a novel DP receptor. Blood 98, 1942-1948 (2001).
9. Hirai H, Tanaka K, Yoshie O et al.: Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven transmembrane receptor CRTH2. J. Exp. Med. 193, 255-261 (2001).
10. Woodward DF, Sapada CS, Hawley SB et al.: Further studies on ocular responses to DP receptor stimulation. Eur. J. Pharmacol. 230, 327-333 (1993).
11. Sawyer N, Cauchon E, Chateauneuf A et al.: Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br. J. Pharmacol. 137, 1163-1172 (2002).
12. Iwasaki M, Nagata K, Takano S et al.: Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J. Invest. Dermatol. 119, 609-616 (2002).
13. Cosmi L, Annunziato F, Galli MIG et al.: CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur. J. Immunol. 30, 2972-2979 (2000).
14. Sandig H, Andrew D, Barnes AA et al.: 9 α, 11 β-PGF2 and its stereoisomer PGF2α are novel agonists of the chemo attractant receptor, CRTH2. FEBS Lett. 580, 373-379 (2006).
15. Bohm E, Sturm GJ, Weiglhofer I et al.: 11-dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemo attractant receptor homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J. Biol. Chem. 279, 7663-7670 (2004).
16. Gervais FG, Cruz RP, Chateauneuf A et al.: Selective modulation of chemokinesis, degranulation and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108, 982-988 (2001).
17. Nagata K Hirai H: The second PGD2 receptor CRTH2: structure, properties and functions in leukocytes. Prostaglandins Leukot. Essent. Fatty Acids 69, 169-177 (2003).
18. Huang JL, Gao PS, Mathias RA et al.: Sequence variants of the gene encoding chemo attractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability. Hum. Mol. Genet. 13, 2691-2697 (2004).
19. Boumiza R, Debard AL, Monneret G: The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin. Mol. Allergy 3, 9 (2005).
20. Yoshimura-Uchiyama C, Iikura M, Yamaguchi M et al.: Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemo attractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin. Exp. Allergy 34, 1283-1290 (2004).
21. Tedesch i A, Lorini M, Suli C et al.: Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin. Exp. Dermatol. 32, 568-570 (2007).
22. Hosseini Farahabadi S, Tavakkol-Afshari J, Ganjali R et al.: Association between the polymorphism of TGF-β1 gene promoter (-509C>T) and idiopathic chronic urticaria. Iran J. Allergy Asthma Immunol. 5, 109-113 (2006).
23. Guttman-Yassky E, Bergman R, Maor C et al.: The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared with respiratory allergy patients and healthy individuals. J. Eur. Acad. Dermatol. Venereol. 21, 35-39 (2007).
24. Owoeye OA, Aina OF, Omoluabi PF et al.: An assessment of emotional pain among subjects with chronic dermatological problems in Lagos, Nigeria. Int. J. Psychiatry Med. 37, 129-138 (2007).
25. Yu-Jin S, Cheol-Kweon J, Soo-Jin L et al.: The clinical significance of thyroid auto-antibodies in patients with chronic idiopathic urticaria. Korean J. Asthma Allergy Clin. Immunol. 20, 528-534 (2000).
26. Satoh T, Moroi R, Aritake K et al.: Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J. Immunol. 177, 2621-2629 (2006).
27. Maezawa Y, Nakajima H, Seto Y et al.: IgE-dependent enhancement of Th2 cell-mediated allergic inflammation in the airways. Clin. Exp. Immunol. 135, 12-18 (2004).
28. Maezawa Y, Nakajima H, Kumano K et al.: Role of IgE in Th2 cell-mediated allergic airway inflammation. Int. Arch. Allergy Immunol. 131, 2-6 (2003).
29. Hashimoto Y, Arai I, Tanaka M et al.: Prostaglandin D2 inhibits IgE-mediated scratching by suppressing histamine release from mast cells. J. Pharmacol. Sci. 98, 90-93 (2005).
30. Murphy KM, Reiner SL: The lineage decisions of helper T cells. Nat. Rev. 2, 933-944 (2002).
31. De Fanis U, Mori F, Kurnat RJ et al.: GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood 109, 4343-4350 (2007).
32. Ting CN, Olson MC, Barton KP et al.: Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384, 474-478 (1996).
33. Monticelli S, Solymar DC, Rao A: Role of NFAT proteins in IL13 gene transcription in mast cells. J. Biol. Chem. 279, 36210-36218 (2004).
34. Taghon T, Yui MA, Rothenberg EV: Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat. Immunol. 8, 845-855 (2007).
35. Quapp R, Madsen N, Cameron L: Characterization of the promoter of human CRTh2, a prostaglandin D2 receptor. Biochem. Biophys. Res. Commun. 363, 948-953 (2007).